trending Market Intelligence /marketintelligence/en/news-insights/trending/32s-nY4g8SdDG3-5chElPA2 content esgSubNav
In This List

Corbus raises $37.4M in stock offering after underwriters exercise option

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Corbus raises $37.4M in stock offering after underwriters exercise option

Corbus Pharmaceuticals Holdings Inc. raised about $37.4 million in total proceeds from its public offering, with underwriters exercising their option to buy an additional 697,500 common shares at $7 apiece.

The clinical stage drug development company said a total of 5,347,500 shares, including the underwriters' option, were sold.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering, while JMP Securities LLC and Raymond James & Associates Inc. are acting as co-managers.